Literature DB >> 3280235

Fuchs' dystrophy.

S E Wilson1, W M Bourne.   

Abstract

Fuchs' dystrophy is an inherited disorder of unknown etiology in which the corneal endothelial cells develop morphologic and functional abnormalities. Clinically, the disease progresses slowly over a period of 20 or more years from asymptomatic cornea guttata to corneal edema with decreased vision and pain. Pathologic studies suggest abnormalities in endothelial function occurring early in life, although symptoms usually do not appear until middle age. The definitive treatment for Fuchs' dystrophy is penetrating keratoplasty. Recent findings regarding the pathophysiology of the disease have increased our understanding of it and have suggested areas for future research.

Entities:  

Mesh:

Year:  1988        PMID: 3280235

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  58 in total

1.  A locus for posterior polymorphous corneal dystrophy (PPCD3) maps to chromosome 10.

Authors:  Satoko Shimizu; Charles Krafchak; Nobuo Fuse; Michael P Epstein; Miriam T Schteingart; Alan Sugar; Maya Eibschitz-Tsimhoni; Catherine A Downs; Frank Rozsa; Edward H Trager; David M Reed; Michael Boehnke; Sayoko E Moroi; Julia E Richards
Journal:  Am J Med Genet A       Date:  2004-11-01       Impact factor: 2.802

2.  A multicenter study to map genes for Fuchs endothelial corneal dystrophy: baseline characteristics and heritability.

Authors:  Megan D Louttit; Laura J Kopplin; Robert P Igo; Jeremy R Fondran; Angela Tagliaferri; David Bardenstein; Anthony J Aldave; Christopher R Croasdale; Marianne O Price; George O Rosenwasser; Jonathan H Lass; Sudha K Iyengar
Journal:  Cornea       Date:  2012-01       Impact factor: 2.651

3.  Corneal abnormalities early in the course of Fuchs' endothelial dystrophy.

Authors:  Sejal R Amin; Keith H Baratz; Jay W McLaren; Sanjay V Patel
Journal:  Ophthalmology       Date:  2014-08-22       Impact factor: 12.079

4.  Association of smoking and other risk factors with Fuchs' endothelial corneal dystrophy severity and corneal thickness.

Authors:  Xiaolin Zhang; Robert P Igo; Jeremy Fondran; V Vinod Mootha; Matt Oliva; Kristin Hammersmith; Alan Sugar; Jonathan H Lass; Sudha K Iyengar
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-08-27       Impact factor: 4.799

5.  Mutations in AGBL1 cause dominant late-onset Fuchs corneal dystrophy and alter protein-protein interaction with TCF4.

Authors:  S Amer Riazuddin; Shivakumar Vasanth; Nicholas Katsanis; John D Gottsch
Journal:  Am J Hum Genet       Date:  2013-10-03       Impact factor: 11.025

6.  Increased clusterin expression in Fuchs' endothelial dystrophy.

Authors:  Ula V Jurkunas; Maya S Bitar; Ian Rawe; Deshea L Harris; Kathryn Colby; Nancy C Joyce
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-03-31       Impact factor: 4.799

Review 7.  Molecular bases of corneal endothelial dystrophies.

Authors:  Thore Schmedt; Mariana Mazzini Silva; Alireza Ziaei; Ula Jurkunas
Journal:  Exp Eye Res       Date:  2011-08-10       Impact factor: 3.467

8.  Peripheral Endothelial Cell Count Is a Predictor of Disease Severity in Advanced Fuchs Endothelial Corneal Dystrophy.

Authors:  Zeba A Syed; Jennifer A Tran; Ula V Jurkunas
Journal:  Cornea       Date:  2017-10       Impact factor: 2.651

9.  In Vivo Confocal Microscopy Shows Alterations in Nerve Density and Dendritiform Cell Density in Fuchs' Endothelial Corneal Dystrophy.

Authors:  Shruti Aggarwal; Bernardo M Cavalcanti; Laura Regali; Andrea Cruzat; Monique Trinidad; Candice Williams; Ula V Jurkunas; Pedram Hamrah
Journal:  Am J Ophthalmol       Date:  2018-09-06       Impact factor: 5.258

10.  Endothelial cell microRNA expression in human late-onset Fuchs' dystrophy.

Authors:  Mario Matthaei; Jianfei Hu; Laura Kallay; Charles G Eberhart; Claus Cursiefen; Jiang Qian; Eva-Maria Lackner; Albert S Jun
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-01-09       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.